Table of Contents

If you’ve been prescribed Zepbound or are considering it, your biggest question is likely:

“How do I get my insurance to pay for it?”

At over $1,200 a month, paying out of pocket isn’t realistic for most people. Yet approval often comes down to how well you can navigate a maze of changing rules, complex forms, and medical requirements that vary by plan.

This guide gives you a clear, step-by-step plan on how to get insurance to cover Zepbound. You’ll see exactly what to say, what to give your doctor, and what paperwork to prepare, plus tips from real cases and studies so you know what actually works.

Key Takeaways

  • Insurers base approvals on strict criteria. Your diagnosis, BMI, and related conditions must align with what the FDA has approved for Zepbound.
  • Plan rules vary widely. Two people with the same insurer can get different answers because coverage depends on your specific plan’s formulary, restrictions, and exceptions.
  • Complete, precise medical records with exact numbers (e.g., BMI, lab values, sleep study results) are often the deciding factor for coverage.
  • Many insurers require proof that you’ve tried and failed lifestyle changes or other weight loss medications before approving Zepbound.
  • Many denials get reversed if you correct missing information, add strong supporting evidence, and present a clear medical necessity case.
  • Your doctor is your best ally. Providers can supply the right codes, language, and records needed for approval and appeals, as well as track your progress for renewals.

How To Get Insurance To Cover Zepbound

physician speaking with patient

You can improve your chances of getting coverage if you understand how insurance companies decide, what they look for in your records, and how to navigate the approval process.

Step 1: Understand what Zepbound is for

Zepbound is an injectable medication that works on two hormone pathways, GLP-1 and GIP, to help with chronic weight management. The FDA has approved it for:

    • Adults with obesity (BMI is more than/equal to 30), or
    • Adults who are overweight (BMI is more than/equal to 27) and have at least one weight-related condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea (OSA).

Your insurance company’s decision will be tied to the FDA-approved uses. If you meet one of these criteria and it’s clearly documented in your medical record, you’re already one step ahead.

Example: If your BMI is 32 and you have high blood pressure, your doctor should document both in your chart. If you have OSA, they should include the results of your sleep study (e.g., “AHI = 25, consistent with moderate OSA”). Insurance reviewers often look for exact numbers like this.

Step 2: Find out if your plan covers Zepbound before you even apply

Most questions focus on what insurance covers Zepbound, but what really matters is your specific plan. Two people with Aetna, for example, could have different outcomes. One may have coverage for Zepbound because it’s included in their plan, while the other may not if their plan excludes it.

Here’s where you save yourself weeks of frustration. Check your insurance plan’s formulary (the list of drugs they cover) before your doctor sends a prescription.

How to do it:

    1. Go to your insurance provider’s website and look for “Formulary” or “Drug List.”
    2. Search for “Zepbound” or “tirzepatide.”
    3. See if it says:
        • “PA” (Prior Authorization required)
        • “Step therapy” (you must try other drugs first)
        • “Excluded” (not covered at all unless you get an exception)

Example: If you have Aetna and the formulary says “PA and step therapy,” they might make you try a cheaper weight loss drug like orlistat before approving Zepbound, unless you have a medical reason you can’t take it, which your doctor can document.

Special Cases

  • If you’re on Medicaid: Each state’s Medicaid program has its own list of covered medications. According to the Kaiser Family Foundation, 13 state Medicaid programs cover GLP-1s for obesity treatment. These states include:
      1. California (no PA needed)
      2. Delaware
      3. Kansas
      4. Massachusetts
      5. Michigan
      6. Minnesota
      7. Mississippi
      8. New Hampshire
      9. North Carolina
      10. Pennsylvania
      11. Rhode Island
      12. Virginia
      13. Wisconsin
  • If you’re on Medicare: Medicare won’t cover Zepbound if it’s prescribed only for weight loss. It’s covered only for OSA. The good news is that the current administration has approved a five-year pilot program, allowing Medicaid and Medicare Part D plans to cover GLP-1 weight-loss drugs starting in April 2026 for Medicaid and January 2027 for Medicare. Participation is voluntary for insurers and states.
  • If you’re on an employer plan: Ask HR whether your plan opted into GLP-1 obesity coverage and whether it uses PBM programs that cap monthly out-of-pocket costs (some plans now offer $200/month caps for eligible members). If not covered, ask whether your employer offers an exception process for high-risk patients (e.g., severe OSA, cardiometabolic complications).

Step 3: Get your documentation in order

Insurance companies love paperwork. Missing one piece can cause an automatic denial.

Here’s what you should have in your file:

Proof of diagnosis

For weight management, this includes documenting your baseline measurements, such as:

    • Weight
    • BMI
    • Waist circumference
    • Obesity diagnosis (with the corresponding ICD-10 code)
    • Any obesity-related complications (with their respective codes)

For OSA approvals, include the following:

    • Confirmed diagnosis of OSA
    • Results of a polysomnography (sleep study)
    • Symptom scores (e.g., ESS)

Relevant ICD-10 Codes

The following ICD-10 codes are commonly associated with Zepbound. This list may not include all possible codes, so check a coding resource for more options.

Note: Appropriate coding varies by individual case, insurance policy, and care environment. The submitting provider is responsible for accuracy. Pharma Giant makes no assurances about payment or coverage.

  • E66 – Overweight and obesity
  • E66.1 – Drug-induced obesity
  • E66.2 – Morbid (severe) obesity with alveolar hypoventilation
  • E66.3 – Overweight
  • E66.8 – Other obesity
    • E66.81 – Obesity class
    • E66.811 – Obesity, class 1
    • E66.812  – Obesity, class 2
    • E66.813 – Obesity, class 3
    • E66.89 – Other obesity not elsewhere classified
  • E66.9  – Obesity, unspecified
  • G47.33 – Obstructive sleep apnea (adult) (pediatric)
  • I10 – Essential (primary) hypertension
  • E78.5 – Hyperlipidemia, unspecified
  • E11 – Type 2 diabetes mellitus
  • I51.9 – Heart disease, unspecified

Failed or insufficient response to lifestyle program

For weight loss, most plans require 3-6 months of structured diet/physical activity, documented in the chart, including the names of programs, registered dietitian notes, or primary-care visit notes. This may involve:

    • Nutritional counseling
    • Exercise programs (unless a medical condition prevents physical activity)
    • Behavioral changes

Your medical records should include details on your adherence to a structured dietary plan, often requiring a daily 500-calorie deficit, and an exercise regimen of at least 150 minutes of physical activity per week. This helps confirm that Zepbound is being used as a next step, not as the first treatment option.

If you’re using Continuous Positive Airway Pressure (CPAP) for OSA, you may need to keep adherence notes. CPAP compliance usually means using the machine for at least four hours per night on at least five nights each week.

Medication history

Insurers may require step therapy, which means starting with a different weight-loss drug before Zepbound. Usually, this involves a non-GLP-1 like phentermine, orlistat, or similar drugs. If these can’t be tolerated, insurers may verify you’re not already on another GLP-1.

For instance, Aetna Medicare Better Health considers a trial unsuccessful if:

    • Benzphetamine, diethylpropion, phendimetrazine, or phentermine: Less than 10 lbs lost after three months.
    • Orlistat: Less than 10 lbs lost after six months.
    • GLP-1 receptor agonists (e.g., Saxenda): Less than a 5% weight reduction after six months.

If these treatments don’t work or cause side effects you can’t tolerate, you may qualify for Zepbound.

The same goes for OSA. Examples of therapies used to manage symptoms of OSA include:

    • Positive airway pressure (PAP) therapy
    • Oral appliances (eg, mouth guards)
    • Other stimulants such as Provigil (modafinil) and Nuvigil (armodafinil)

Why Zepbound is medically necessary

In some cases, you may need to explain through a letter why Zepbound is necessary. To strengthen your case, include additional medical documentation, such as:

    • Specialist notes supporting your need for treatment
    • A detailed weight history showing past attempts at weight loss
    • Tried/failed, contraindications, intolerance notes of previous treatments
    • If your plan prefers Wegovy (semaglutide), provide evidence of your unsuccessful weight loss attempt with Wegovy and reference studies showing that tirzepatide delivers greater weight loss and better cost-effectiveness.

This is to prove that you meet the intent of the coverage policy.

Safety screening

Zepbound is only approved for adults, so you generally must be at least 18 years old. You should not have a history of an eating disorder, including anorexia or bulimia.

Your doctor should also rule out contraindications (e.g., personal/family history of medullary thyroid carcinoma or MEN2), and note your gastrointestinal history, pancreatitis risk, and any medications that increase the risk of hypoglycemia.

If you are pregnant or planning to become pregnant, certain insurers (particularly state-funded programs) may require confirmation that your obesity is significantly affecting your health to justify medical treatment.

Step 4: Track your progress consistently

Even if you get approved, many insurers will review your progress after 12-16 weeks to decide whether to keep paying. Most want to see at least 4-5% weight loss from your starting weight. So, if your baseline weight is 240 lbs, 5% weight loss is 12 lbs. If you’re at 228 lbs by week 12 and it’s documented, your continuation request is much more likely to be approved.

How to prepare:

    • Weigh yourself at the same time of day each week.
    • Keep a log (paper, app, or your patient portal).
    • If you’re treating OSA, track symptoms (daytime sleepiness, snoring frequency) and CPAP use if you have it.

Below is a community-created guide from Reddit that can help you choose apps and tools for tracking weight loss and health progress while on Zepbound.

App Name Supported Platforms Key Features
Shotsy iOS, Android Shotsy records injection details (dose, site, date/time), weight changes, and nutrition data like protein and calories. Includes a visual medication level tracker, symptom log with a calendar view, and easy-to-read charts. Syncs with Apple Health for integrated health tracking.
Glapp Web, iOS, Android Displays your weekly medication cycle so you can see when Zepbound is at peak effect or wearing off. Tracks injection info, weight, side effects, hunger, and “food noise.” Includes charts, reports, and helpful tips aligned with medical guidance. Created by a developer who also uses tirzepatide.
GLP-1 Tracker – Tirzepatide iOS Records weekly injection data, side effects, hunger levels, and body metrics such as weight, calorie intake, protein, and water consumption. Offers trend charts and medication level visuals.
Disclaimer: The list is adapted from publicly available discussions on Reddit. Original credit goes to the contributing Reddit users.

Step 5: If you’re denied, appeal immediately

Many patients get approved on appeal, especially if they fix the missing details. The first stage of an appeal is typically an internal review, where your insurer re-examines your case, often with new evidence or by a different reviewer.

Your denial notice will outline how to file, along with the deadline, which is usually 60-180 days for private insurance. Medicare Advantage and Part D appeals follow separate timelines.

According to a US Government Accountability Office study, 39-59% of internal appeals result in the insurer reversing their original denial.

Here’s what you should do:

    • Read the denial letter carefully. It will say exactly what’s missing.
    • Have your doctor update the requirements with the missing info.
    • Add an evidence appendix that summarizes the results from trials (SURMOUNT trials for obesity, SURMOUNT-OSA trials for sleep apnea), plus FDA approval excerpts.
    • Request a peer-to-peer review between your doctor and the insurance medical director.

If you lose the internal appeal, you might still be able to move to a second round, often called an external review. This is handled by an outside organization, such as your state’s insurance department or an independent review board.

At each appeal stage, be sure to submit any new supporting evidence and restate your case for medical necessity. If your denial says “Patient did not meet BMI criteria,” but you have a BMI of 29 and moderate OSA, your doctor can resubmit with your sleep study to show you do meet the FDA-approved OSA indication.

Step 6: Keep your doctor in the loop

Your best ally in getting coverage is your doctor. Update them if your weight loss is on track, and let them know if you get side effects. Ask them to save all your records because you’ll need them for renewals.

Step 7: Be persistent!

The process can feel slow and frustrating, but persistence pays off. Many patients go from denial to approval simply because they didn’t quit after the first “no.”

Final Thoughts

Getting insurance to cover Zepbound comes down to meeting the FDA-approved criteria, proving it with solid documentation, and following your plan’s rules. Confirm your plan covers it before applying. Have your diagnosis, BMI, comorbidity details, and past treatment history clearly recorded. Track your progress from the start, as most insurers want proof of results within 12 to 16 weeks.

If you’re denied, appeal right away and fix any missing details. Use trial data and a clear medical necessity statement to strengthen your case. Keep your doctor involved at every step, and don’t quit after the first “no.” Persistence, accurate records, and quick action are what turn denials into approvals.

Frequently Asked Questions

Some insurance plans cover Zepbound, but approval often depends on meeting specific medical criteria, such as BMI and related health conditions, and completing prior authorization steps.
Coverage varies by provider, but certain commercial plans and a few Medicaid programs in select states may include Zepbound for weight loss if eligibility requirements are met.
It may be covered if your plan lists it on the formulary and you meet your insurer’s medical necessity standards. However, coverage is not guaranteed.
Denials can happen if you don’t meet BMI or health condition criteria, lack required documentation, or haven’t tried other treatments first as your insurer requests.
Approval timelines differ, but it typically takes anywhere from a few days to several weeks, depending on your insurer’s process and how quickly your doctor submits information.
You can appeal the decision, explore manufacturer savings programs, check for lower-cost alternatives, or consider other FDA-approved weight loss medications.

Sources

Summer, J. V., & Summer, J. V. (2025, July 9). What is CPAP Compliance? Sleep Foundation. https://www.sleepfoundation.org/cpap/cpap-compliance

Rodriguez, P. J., Cartwright, B. M. G., Gratzl, S., Brar, R., Baker, C., Gluckman, T. J., & Stucky, N. L. (2024). Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Internal Medicine, 184(9), 1056. https://doi.org/10.1001/jamainternmed.2024.2525

Hwang, J. H., Laiteerapong, N., Huang, E. S., & Kim, D. D. (2025). Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and semaglutide in US Adults. JAMA Health Forum, 6(3), e245586. https://doi.org/10.1001/jamahealthforum.2024.5586

Niasse, A. (2025, May 22). Cigna to offer $200 Wegovy, Zepbound weight-loss benefit. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/cigna-offer-200-wegovy-zepbound-weight-loss-benefit-2025-05-21/

Zepbound PA with Limit 6192-C P08-2024_R – Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan. (n.d.). Aetna. https://www.aetna.com/products/rxnonmedicare/data/2024/Zepbound_PA_with_Limit_6192-C_P08-2024_R.html

Savings Card, Cost & Coverage Support | Zepbound® (tirzepatide). (n.d.). Zepbound® (Tirzepatide) Injection. https://zepbound.lilly.com/coverage-savings

Antiobesity Agents Aetna ONLY for Specific States PA with Limit 5098-C UDR 08-2023 v6 – Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan. (n.d.). Aetna. https://www.aetna.com/products/rxnonmedicare/data/2025/Antiobesity_Agents_Aetna_ONLY_for_Specific_States_PA_with_Limit_5098-C_UDR_08-2023_v6.html

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity | Eli Lilly and Company. (n.d.). Eli Lilly and Company. https://investor.lilly.com/news-releases/news-release-details/fda-approves-zepboundr-tirzepatide-first-and-only-prescription